Iatrogenic Causes of Urothelial Cancer of the Upper Urinary Tract and Bladder.
作者信息
Messing Edward M
机构信息
University of Rochester Medical Center, Rochester, NY, USA.
出版信息
Bladder Cancer. 2021 Aug 31;7(3):385-387. doi: 10.3233/BLC-219608. eCollection 2021.
Abstract
摘要
相似文献
1
Iatrogenic Causes of Urothelial Cancer of the Upper Urinary Tract and Bladder.上尿路和膀胱尿路上皮癌的医源性病因
Bladder Cancer. 2021 Aug 31;7(3):385-387. doi: 10.3233/BLC-219608. eCollection 2021.
2
Routine Surveillance of Upper Urinary Tract Imaging for Diagnosing Upper Urinary Tract Urothelial Cancer Recurrence in Patients with Nonmuscle Invasive Bladder Cancer.非肌层浸润性膀胱癌患者上尿路成像的常规监测用于诊断上尿路尿路上皮癌复发
Adv Urol. 2024 May 21;2024:5894288. doi: 10.1155/2024/5894288. eCollection 2024.
3
Epidemiology of urothelial carcinoma.尿路上皮癌的流行病学
Int J Urol. 2017 Oct;24(10):730-734. doi: 10.1111/iju.13376. Epub 2017 May 21.
4
Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract.淋巴结切除术在膀胱和上尿路尿路上皮癌治疗中的作用。
Int J Urol. 2012 Aug;19(8):710-21. doi: 10.1111/j.1442-2042.2012.03009.x. Epub 2012 Apr 19.
5
Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?膀胱和上尿路尿路上皮癌的分子特征的前瞻性比较——是否有生物学不一致的证据？
J Urol. 2014 Apr;191(4):926-31. doi: 10.1016/j.juro.2013.09.031. Epub 2013 Sep 20.
6
Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies.共聚焦激光内镜检查在膀胱和上尿路尿路上皮癌诊断中的应用：两项前瞻性探索性研究方案
JMIR Res Protoc. 2018 Feb 7;7(2):e34. doi: 10.2196/resprot.8862.
7
Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.临床与病理 T 分期在上尿路尿路上皮癌中的差异：日本基于医院癌症登记数据的分析。
Int J Urol. 2021 Aug;28(8):814-819. doi: 10.1111/iju.14583. Epub 2021 May 19.
8
FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.FGF7 过表达是上尿路和膀胱尿路上皮癌患者的独立预后指标。
J Urol. 2015 Jul;194(1):223-9. doi: 10.1016/j.juro.2015.01.073. Epub 2015 Jan 23.
9
Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.卡介苗治疗失败的患者可能是非肌层浸润性膀胱癌，原因可能是泌尿科医生未能检测到上尿路和尿道的尿路上皮癌。
Eur Urol. 2014 Apr;65(4):825-31. doi: 10.1016/j.eururo.2013.09.049. Epub 2013 Oct 9.
10
Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的临床意义。
Int J Urol. 2016 May;23(5):378-84. doi: 10.1111/iju.13054. Epub 2016 Jan 18.
本文引用的文献
1
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.上尿路尿路上皮癌诊断方式对根治性肾输尿管切除术术后膀胱内复发的影响：单中心系列研究和更新的荟萃分析。
J Urol. 2021 Sep;206(3):558-567. doi: 10.1097/JU.0000000000001834. Epub 2021 Apr 28.
2
Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis.输尿管支架置入是否会增加膀胱癌患者发生同期上尿路尿路上皮癌的风险？系统评价和荟萃分析。
J Urol. 2021 Apr;205(4):956-966. doi: 10.1097/JU.0000000000001548. Epub 2020 Dec 7.
3
Lynch syndrome and urologic malignancies: a contemporary review.林奇综合征与泌尿系统恶性肿瘤：当代综述
Curr Opin Urol. 2019 Jul;29(4):357-363. doi: 10.1097/MOU.0000000000000639.
4
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States.中国与美国上尿路尿路上皮癌的临床病理特征和肿瘤学结局的多机构比较。
J Urol. 2017 May;197(5):1208-1213. doi: 10.1016/j.juro.2016.11.094. Epub 2016 Nov 22.
5
Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial.经尿道膀胱肿瘤切除术治疗表浅性膀胱癌后膀胱内灌注吡柔比星（THP）预防膀胱癌复发的前瞻性随机 II 期临床试验：THP 单药治疗研究组试验。
J Clin Oncol. 2013 Apr 10;31(11):1422-7. doi: 10.1200/JCO.2012.45.2128. Epub 2013 Mar 4.
6
Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.上尿路尿路上皮细胞癌：位置是膀胱合并癌的预测因素。
World J Urol. 2013 Feb;31(1):141-5. doi: 10.1007/s00345-012-0877-2. Epub 2012 May 3.
7
Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).肾输尿管切除术治疗原发性上尿路尿路上皮癌后膀胱肿瘤的预防：单次术后膀胱内给予丝裂霉素 C 的前瞻性、多中心、随机临床试验（ODMIT-C 试验）。
Eur Urol. 2011 Oct;60(4):703-10. doi: 10.1016/j.eururo.2011.05.064. Epub 2011 Jun 12.
8
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).与使用一种中草药（广防己）相关的尿路上皮癌。
N Engl J Med. 2000 Jun 8;342(23):1686-92. doi: 10.1056/NEJM200006083422301.
9
Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics.与含非那西丁镇痛药滥用相关的膀胱和输尿管肿瘤。
Acta Pathol Microbiol Scand A. 1977 Nov;85(6):768-74. doi: 10.1111/j.1699-0463.1977.tb03892.x.
Zotero 插件